Renhuan Xu | Chief Executive Officer ARV Technologies
ARV Technologies is a start-up biotechnology company focused on developing innovative vaccines to address critical unmet medical needs in areas such as infectious diseases and oncology.
Appearances:
WVIC/WAC Day 1 - Nov 29 @ 15:35
Preclinical evaluation of a low-dose universal SARS-CoV-2 mRNA vaccine
Renhuan Xu / Preclinical evaluation of a low-dose universal SARS-CoV-2 mRNA vaccine
Renhuan Xu, Chief Executive Officer, ARV Technologies
ARV Technologies is a start-up biotechnology company focused on developing innovative vaccines to address critical unmet medical needs in areas such as infectious diseases and oncology.